The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Evolution of Drug Resistance in Experimental Populations of Candida albicans
Open accessAbstract
Adaptation to inhibitory concentrations of the antifungal agent fluconazole was monitored in replicated experimental populations founded from a single, drug-sensitive cell of the yeast Candida albicans and reared over 330 generations. The concentration of fluconazole was maintained at twice the MIC in six populations; no fluconazole was added to another six populations. All six replicate populations grown with fluconazole adapted to the presence of drug as indicated by an increase in MIC; none of the six populations grown without fluconazole showed any change in MIC. In all populations evolved with drug, increased fluconazole resistance was accompanied by increased resistance to ketoconazole and itraconazole; these populations contained ergosterol in their cell membranes and were amphotericin sensitive. The increase in fluconazole MIC in the six populations evolved with drug followed different trajectories, and these populations achieved different levels of resistance, with distinct overexpression patterns of four genes involved in azole resistance: the ATP-binding cassette transporter genes, CDR1 and CDR2; the gene encoding the target enzyme of the azoles in the ergosterol biosynthetic pathway, ERG11; and the major facilitator gene, MDR1. Selective sweeps in these populations were accompanied by additional genomic changes with no known relationship to drug resistance: loss of heterozygosity in two of the five marker genes assayed and alterations in DNA fingerprints and electrophoretic karyotypes. These results show that chance, in the form of mutations that confer an adaptive advantage, is a determinant in the evolution of azole drug resistance in experimental populations of C. albicans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Selective sweeps in response to drug selection are also observed in experimental populations of C. albicans during the evolution of azole resistance in vitro [107].”
From Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata (2012) · cites this paper as [107]
In the citing paper
“The impact of drug concentration on the spectrum and effect of mutations acquired during adaptation is not known for any fungal pathogen, and how the specific level of a given stress influences the distribution of beneficial mutations has been poorly explored in general.”
From Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans (2023) · cites this paper as Cowen et al. 2000
In the citing paper
“Overall, the impact of genetic and environmental factors, including FLC concentration, on the acquisition of drug resistance and tolerance phenotypes is not known.”
From Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans (2023) · cites this paper as Cowen et al. 2000
In the citing paper
“In one example, six lineages from one C. albicans strain were maintained at increasing concentrations of FLC for 300–400 generations, where the MIC50 was quantified every 10–20 generations and the drug concentration was increased to twice the MIC50, to a maximum concentration of 128 μg/ml FLC (Cowen et al. 2000).”
From Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans (2023) · cites this paper as Cowen et al. 2000
In the citing paper
“Prior studies into how antifungal drugs impact the spectrum of mutations observed during adaption primarily focused on increasing FLC concentrations or on short-term evolution experiments in a single concentration of FLC (Cowen et al. 2000; Anderson et al. 2003; Mount et al. 2018; Rybak et al. 2020; Burrack et al. 2022).”
From Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans (2023) · cites this paper as Cowen et al. 2000
In the citing paper
“For example, Cowen et al. [150] serially propagated six experimental populations of C. albicans derived from a single colony for 330 generations in medium supplemented with fluconazole at a concentration doubling their MIC.”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [150]
In the citing paper
“Both methods have been successfully used to study the emergence of drug resistance in Candida yeasts [150,151].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [150]
In the citing paper
“Loss of heterozygosity at gene loci of isolates serially passaged in azole-containing media, as well as laboratory strains passaged through mice models of haematogenously disseminated disease, both suggest that significant genetic rearrangements take place as a result of host and drug stress.”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans (2020) · cites this paper as [152]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Lenski, R. E., & Travisano, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.6808 · Cited by 1,020
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Self-citationSanglard, D., Ischer, F., Monod, M., & Bille, J. (1997) · Microbiology · doi:10.1099/00221287-143-2-405 · Cited by 587
Self-citationExperimental Tests of the Roles of Adaptation, Chance, and History in Evolution
Travisano, M., Mongold, J. A., Bennett, A. F., & Lenski, R. E. (1995) · Science · doi:10.1126/science.7809610 · Cited by 503
Systematic changes in gene expression patterns following adaptive evolution in yeast
Ferea, T., Botstein, D., Brown, P. O., & Rosenzweig, R. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9721 · Cited by 479
Sanglard, D., Ischer, F., Koymans, L. M. H., & Billé, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465
Self-citationCollart, M. A., & Oliviero, S. (1993) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb1312s23 · Cited by 457
Cited by
Sorted by citations
Evolution Experiments with Microorganisms: The Dynamics and Genetic Bases of Adaptation
Elena, S. F., & Lenski, R. E. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1088 · Cited by 1,386
The Evolution of Transcriptional Regulation in Eukaryotes
Wray, G. A. (2003) · Molecular Biology and Evolution · doi:10.1093/molbev/msg140 · Cited by 1,229
Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733
The Evolution of Fungicide Resistance
Lucas, J. A., Hawkins, N. J., & FRAAIJE, B. A. (2014) · Advances in applied microbiology · doi:10.1016/bs.aambs.2014.09.001 · Cited by 652
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576
Self-citationMolecular Evolution of Antifungal Drug Resistance
Robbins, N., Caplan, T., & Cowen, L. E. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-030117-020345 · Cited by 441
Self-citationEvolution of antifungal-drug resistance: mechanisms and pathogen fitness
Anderson, J. B. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1179 · Cited by 375
Self-citationGanley, A. R. D., & Kobayashi, T. (2007) · Genome Research · doi:10.1101/gr.5457707 · Cited by 362
Selmecki, A. M., Dulmage, K., Cowen, L. E., Anderson, J. B., & Berman, J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000705 · Cited by 319
Self-citationTerpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle
Zore, G. B., Thakre, A. D., Jadhav, S., & Karuppayil, S. M. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.03.008 · Cited by 319
The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.
Cowen, L. E. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1835 · Cited by 311
Self-citationGenotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates
Coste, A., Selmecki, A., Forche, A., Diogo, D., Bougnoux, M.-E., d'Enfert, C., Berman, J., & Sanglard, D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00151-07 · Cited by 305
Self-citationRegulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300
An update on antifungal targets and mechanisms of resistance in Candidaalbicans
Akins, R. A. (2005) · Medical Mycology · doi:10.1080/13693780500138971 · Cited by 291
Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.
Cowen, L. E., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00041-08 · Cited by 285
Self-citationVermitsky, J.-P., & Edlind, T. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3773-3781.2004 · Cited by 285
Genomic Plasticity of the Human Fungal Pathogen Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2010) · Eukaryotic Cell · doi:10.1128/ec.00060-10 · Cited by 247
Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens
Ksiezopolska, E., & Gabaldón, T. (2018) · Genes · doi:10.3390/genes9090461 · Cited by 230
Candida albicans drug resistance—Another way to cope with stress
Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Tanabe, K., Niimi, M., & Monk, B. C. (2007) · Microbiology · doi:10.1099/mic.0.2007/010405-0 · Cited by 208
Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
Singh-Babak, S. D., Babak, T., Diezmann, S., Hill, J. A., Xie, J. L., Chen, Y.-L., Poutanen, S. M., Rennie, R. P., Heitman, J., & Cowen, L. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002718 · Cited by 205
Self-citationBougnoux, M., Morand, S., & d'Enfert, C. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.4.1290-1297.2002 · Cited by 216
Tavanti, A., Davidson, A. D., Fordyce, M. J., Gow, N. A. R., Maiden, M. C. J., & Odds, F. C. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5601-5613.2005 · Cited by 176
A new role of the rDNA and nucleolus in the nucleus—rDNA instability maintains genome integrity
Kobayashi, T. (2008) · BioEssays · doi:10.1002/bies.20723 · Cited by 172
Compensation of Fitness Costs and Reversibility of Antibiotic Resistance Mutations
Wiesch, P. A. Z., Engelstädter, J., & Bonhoeffer, S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01460-09 · Cited by 174
Karababa, M., Coste, A. T., Rognon, B., Billé, J., & Sanglard, D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3064-3079.2004 · Cited by 161
Self-citationLee, D.-H., & Palsson, B. Ø. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.00373-10 · Cited by 160
Anderson, J. B., Sirjusingh, C., Parsons, A. B., Boone, C., Wickens, C., Cowen, L. E., & Kohn, L. M. (2003) · Genetics · doi:10.1093/genetics/163.4.1287 · Cited by 156
Self-citationHaplotype Mapping of a Diploid Non-Meiotic Organism Using Existing and Induced Aneuploidies
Legrand, M., Forche, A., Selmecki, A. M., Chan, C., Kirkpatrick, D. T., & Berman, J. G. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0040001 · Cited by 153
Evolution of Drug Resistance in Candida Albicans
Cowen, L. E., Anderson, J. B., & Kohn, L. M. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160907 · Cited by 151
Self-citationOdds, F. C., Davidson, A. D., Jacobsen, M. D., Tavanti, A., Whyte, J. A., Kibbler, C. C., Ellis, D. H., Maiden, M. C. J., Shaw, D. J., & Gow, N. A. R. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00934-06 · Cited by 149
Becher, R., Hettwer, U., Karlovský, P., Deising, H. B., & Wirsel, S. G. R. (2010) · Phytopathology · doi:10.1094/phyto-100-5-0444 · Cited by 150
Niewerth, M., Kunze, D., Seibold, M., Schaller, M., Körting, H. C., & Hube, B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1805-1817.2003 · Cited by 145
Population genomics of drug resistance in Candida albicans
Cowen, L. E., Nantel, A., Whiteway, M. S., Thomas, D. Y., Tessier, D. C., Kohn, L. M., & Anderson, J. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102291099 · Cited by 140
Self-citationMultilocus Sequence Typing of Pathogenic Candida Species
Odds, F. C., & Jacobsen, M. D. (2008) · Eukaryotic Cell · doi:10.1128/ec.00062-08 · Cited by 143
Kohli, A., Smriti, N., Mukhopadhyay, K., Rattan, A., & Prasad, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1046-1052.2002 · Cited by 137
Sampaio, P., Gusmão, L., Correia, A., Alves, C., Rodrigues, A. G., Pina‐Vaz, C., Amorim, A., & Pais, C. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.8.3869-3876.2005 · Cited by 134
Molecular Phylogenetics and Epidemiology of Candida Albicans
Odds, F. C. (2009) · Future Microbiology · doi:10.2217/fmb.09.113 · Cited by 123
Pierce, C. G., Chaturvedi, A. K., Lazzell, A. L., Powell, A. T., Saville, S. P., McHardy, S. F., & Lopez-Ribot, J. L. (2015) · npj Biofilms and Microbiomes · doi:10.1038/npjbiofilms.2015.12 · Cited by 124
Adherence of Candida albicans to Silicone Induces Immediate Enhanced Tolerance to Fluconazole
Mateus, C., Crow, S. A., & Ahearn, D. G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3358-3366.2004 · Cited by 113
Cowen, L. E., Kohn, L. M., & Anderson, J. B. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.10.2971-2978.2001 · Cited by 116
Self-citationBecher, R., Weihmann, F., Deising, H. B., & Wirsel, S. G. R. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-52 · Cited by 117
Yeo, M., Maurício, I. L., Messenger, L. A., Lewis, M. D., Llewellyn, M. S., Acosta, N., Bhattacharyya, T., Diosque, P., Carrasco, H. J., & Miles, M. A. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001049 · Cited by 107
Ksiezopolska, E., Schikora-Tamarit, M. À., Beyer, R., Nunez-Rodriguez, J. C., Schüller, C., & Gabaldón, T. (2021) · Current Biology · doi:10.1016/j.cub.2021.09.084 · Cited by 107
Borst, A., Raimer, M. T., Warnock, D. W., Morrison, C. J., & Arthington, B. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.783-787.2005 · Cited by 107
Inducible Azole Resistance Associated with a Heterogeneous Phenotype in Candida albicans
Marr, K. A., Lyons, C. N., Ha, K. C., Rustad, T. R., & White, T. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.52-59.2001 · Cited by 106
Xu, Y., Chen, L., & Li, C. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn015 · Cited by 104
Nishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102
Infrequent Genetic Exchange and Recombination in the Mitochondrial Genome of Candida albicans
Anderson, J. B., Wickens, C., Khan, M., Cowen, L. E., Federspiel, N. A., Jones, T., & Kohn, L. M. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.3.865-872.2001 · Cited by 95
Self-citationSasse, C., Dunkel, N., Schäfer, T., Schneider, S., Dierolf, F., Ohlsen, K., & Morschhäuser, J. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08210.x · Cited by 93
Genetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations
Hill, J. A., Ammar, R., Torti, D., Nislow, C., & Cowen, L. E. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003390 · Cited by 93
Self-citationOral health and morbidity – implications of oral infections on the elderly
Meurman, J. H., & Hämäläinen, P. (2006) · Gerodontology · doi:10.1111/j.1741-2358.2006.00102.x · Cited by 90
Shin, J. H., Chae, M. J., Song, J. W., Jung, S.-I., Cho, D., Kee, S. J., Kim, S. H., Shin, M. G., Suh, S. P., & Ryang, D. W. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00381-07 · Cited by 86
Bernstein, K. A., Reid, R. J. D., Šunjevarić, I., Demuth, K., Burgess, R. C., & Rothstein, R. J. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-08-0691 · Cited by 86
Gee, S. F., Joly, S., Soll, D. R., Meis, J. F. G. M., Verweij, P. E., Polacheck, I., Sullivan, D. J., & Coleman, D. C. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.2.556-574.2002 · Cited by 83
Forche, A., May, G., & Magee, P. T. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.1.156-165.2005 · Cited by 82
Gene Copy Number Polymorphisms in an Arbuscular Mycorrhizal Fungal Population
Corradi, N., Croll, D., Colard, A., Kuhn, G., Ehinger, M., & Sanders, I. R. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.01574-06 · Cited by 86
Muthamil, S., Balasubramaniam, B., Balamurugan, K., & Pandian, S. K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02835 · Cited by 88
Zore, G. B., Thakre, A. D., Rathod, V. S., & Karuppayil, S. M. (2010) · Mycoses · doi:10.1111/j.1439-0507.2009.01852.x · Cited by 81
Does stress induce (para)sex? Implications for Candida albicans evolution
Berman, J. G., & Hadany, L. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.01.004 · Cited by 76
Inactivation of Sterol Δ 5,6 -Desaturase Attenuates Virulence in Candida albicans
Chau, A. S., Gurnani, M., Hawkinson, R., Laverdière, M., Cacciapuoti, A. F., & McNicholas, P. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3646-3651.2005 · Cited by 75
Schubert, S., Rogers, P. D., & Morschhäuser, J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00740-08 · Cited by 73
Ploidy variation as an adaptive mechanism in human pathogenic fungi
Morrow, C. A., & Fraser, J. A. (2013) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2013.01.008 · Cited by 74
Comparison of Human and Soil Candida tropicalis Isolates with Reduced Susceptibility to Fluconazole
Yang, Y.-L., Lin, C.-C., Chang, T.-P., Lauderdale, T.-L. Y., Chen, H., Lee, C.-F., Hsieh, C.-W., Chen, P., & Lo, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034609 · Cited by 73
Stergiopoulos, I., van Nistelrooy, J. G. M., Kema, G. H. J., & Waard, M. A. D. (2003) · Pest Management Science · doi:10.1002/ps.766 · Cited by 72
PDR16‐mediated azole resistance in Candida albicans
Saidane, S., Weber, S., Deken, X. D., St‐Germain, G., & Raymond, M. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05196.x · Cited by 72
Metabolic Characterization of Escherichia coli Strains Adapted to Growth on Lactate
Hua, Q., Joyce, A. R., Palsson, B. Ø., & Fong, S. S. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00527-07 · Cited by 67
Schoustra, S. E., Debets, A. J. M., Slakhorst, M., & Hoekstra, R. F. (2006) · Journal of Evolutionary Biology · doi:10.1111/j.1420-9101.2006.01102.x · Cited by 70
Ploidy dynamics and evolvability in fungi
Wertheimer, N. B., Stone, N. R. H., & Berman, J. G. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0461 · Cited by 68
Antimicrobial peptides: therapeutic potential for the treatment of Candida infections
Danesi, R., Senesi, S., Wout, J. W. V. ’., van Dissel, J. T., Lupetti, A., & Nibbering, P. H. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.2.309 · Cited by 65
Chang, M., Sionov, E., Lamichhane, A. K., Kwon-Chung, K. J., & Chang, Y. C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01751-17 · Cited by 66
Gerstein, A. C., Rosenberg, A., Hecht, I., & Berman, J. (2016) · Microbiology · doi:10.1099/mic.0.000295 · Cited by 63
Myc, A., Vanhecke, T. E., Landers, J. J., Hamouda, T., & Baker, J. R. (2003) · Mycopathologia · doi:10.1023/a:1021129710316 · Cited by 63
Horn, B. W., & Dorner, J. W. (2002) · Mycologia · doi:10.2307/3761688 · Cited by 63
Adaptation by Loss of Heterozygosity in Saccharomyces cerevisiae Clones Under Divergent Selection
James, T. Y., Michelotti, L. A., Glasco, A. D., Clemons, R. A., Powers, R. A., James, E. S., Simmons, D. R., Bai, F., & Ge, S.-H. (2019) · Genetics · doi:10.1534/genetics.119.302411 · Cited by 59
Genome-Wide Single-Nucleotide Polymorphism Map for Candida albicans
Forche, A., Magee, P. T., Magee, B. B., & May, G. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.3.705-714.2004 · Cited by 62
Gerstein, A. C., Kuzmin, A., & Otto, S. P. (2014) · Nature Communications · doi:10.1038/ncomms4819 · Cited by 58
Repositioning the Old Fungicide Ciclopirox for New Medical Uses
Shen, T., & Huang, S. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160530151209 · Cited by 60
Martinez, M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.515 · Cited by 58
Hollomon, D. (2017) · Pest Management Science · doi:10.1002/ps.4607 · Cited by 57
Ganley, A. R. D., & Kobayashi, T. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr117 · Cited by 57
Ibuprofen reverts antifungal resistance onCandida albicansshowing overexpression of CDR genes
Ricardo, E., Costa‐de‐Oliveira, S., Silva-Dias, A., Guerra, J., Rodrigues, A. G., & Pina‐Vaz, C. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00504.x · Cited by 56
Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans
Todd, R. T., Soisangwan, N., Peters, S., Kemp, B., Crooks, T., Gerstein, A., & Selmecki, A. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad009 · Cited by 53
Fruits as the vehicle of drug resistant pathogenic yeasts
Lo, H., Tsai, S.-H., Chu, W.-L., Chen, Y.-Z., Zhou, Z.-L., Chen, H.-F., Lee, C.-F., & Yang, Y.-L. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.06.005 · Cited by 53
Pais, P., Galocha, M., Viana, R., Cavalheiro, M., Pereira, D., & Teixeira, M. C. (2019) · Microbial Cell · doi:10.15698/mic2019.03.670 · Cited by 54
Tanida, T., Rao, F., Hamada, T., Ueta, E., & Osaki, T. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.3883-3890.2001 · Cited by 50
Júnior, L. R. B., Gast, C. E., Bruzual, I., & Wong, B. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku554 · Cited by 49
Serfling, A., Wohlrab, J., & Deising, H. B. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00654-07 · Cited by 48
Carbone, I., & Kohn, L. M. (2001) · Molecular Ecology · doi:10.1046/j.0962-1083.2001.01380.x · Cited by 47
Self-citationYan, L., Zhang, J., Cao, Y., Gao, P., & Jiang, Y. (2007) · Journal of Proteome Research · doi:10.1021/pr060656c · Cited by 46
Loss of Heterozygosity and Its Importance in Evolution
Heil, C. S. (2023) · Journal of Molecular Evolution · doi:10.1007/s00239-022-10088-8 · Cited by 43
Yousefimanesh, H., Amin, M., Robati, M., Goodarzi, H., & Otoufi, M. (2015) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.17341 · Cited by 44
Gerstein, A. C., & Berman, J. G. (2020) · mSphere · doi:10.1128/msphere.00480-20 · Cited by 46
Yan, Z., Hua, H., Xu, Y., & Samaranayake, L. P. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/106583 · Cited by 43
Experimental evolution in fungi: An untapped resource
Fisher, K. J., & Lang, G. I. (2016) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2016.06.007 · Cited by 45
Hryncewicz‐Gwóźdź, A., Kalinowska, K., Plomer-Niezgoda, E., Bielecki, J., & Jagielski, T. (2013) · Mycopathologia · doi:10.1007/s11046-013-9655-y · Cited by 43
Gutiérrez-Alonso, O., Hawkins, N. J., Cools, H. J., Shaw, M. W., & FRAAIJE, B. A. (2017) · Evolutionary Applications · doi:10.1111/eva.12511 · Cited by 43
Fungal resilience and host–pathogen interactions: Future perspectives and opportunities
Brown, A. J. P. (2022) · Parasite Immunology · doi:10.1111/pim.12946 · Cited by 41
Gupta, A. K., Kohli, Y., & Summerbell, R. C. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3260-3266.2001 · Cited by 37
MixedCandida albicansstrain populations in colonized and infected mucosal tissues
Jacobsen, M. D., Duncan, A. D., Bain, J. M., Johnson, E. M., Naglik, J. R., Shaw, D. J., Gow, N. A. R., & Odds, F. C. (2008) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2008.00438.x · Cited by 36
Metadata
- Authors
- Cowen, L. E., Sanglard, D., Calabrese, D., Sirjusingh, C., Anderson, J. B., & Kohn, L. M.
- Affiliations
- University of Toronto (CA)
- Centre Hospitalier Universitaire Vaudois (CH)
- Venue
- Journal of Bacteriology
- Publisher
- American Society for Microbiology
- Published
- 2000-03-15
- Volume
- 182
- Issue
- 6
- Pages
- 1515-1522
- ISSN
- 0021-9193 (ISSN-L)
- 1098-5530
- PMC
- PMC94447
- OpenAlex
- W1973285175
- Cited by
- 207
- References
- 34
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 10 · 2021: 8 · 2020: 3 · 2019: 5 · 2018: 7 · 2017: 9 · 2016: 7 · 2015: 5 · 2014: 8 · 2013: 8 · 2012: 9
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Bacteriology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Pfizer
- Pfizer Canada
- Natural Sciences and Engineering Research Council of Canada
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- Candida albicans, fluconazole resistance, experimental evolution, antifungal resistance, ketoconazole, itraconazole, CDR1, CDR2, ERG11, MDR1, ABC transporters, selective sweeps, loss of heterozygosity, karyotype changes, DNA fingerprinting, minimum inhibitory concentration
- MeSH terms
- Antifungal Agents, Candida albicans, Candidiasis, Oral, Culture Media, Drug Resistance, Microbial, Humans, Karyotyping, Microbial Sensitivity Tests, Colony Count, Microbial, Fluconazole, DNA Fingerprinting, AIDS-Related Opportunistic Infections, Sequence Analysis, DNA, Evolution, Molecular, Loss of Heterozygosity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
